Opinion on Market Dynamics

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

BMS fails to fight off generic competition for Taxol

Published By Datamonitor
15 Sep 2000
CommentWire
CommentWire

Bayer: rethinking pricing strategies

Published By Datamonitor
19 Sep 2000
CommentWire
CommentWire

Eli Lilly: cheeky but risky insulin strategy

Published By Datamonitor
19 Sep 2000
CommentWire
CommentWire

Opel: guilty of breaking competition laws

Published By Datamonitor
21 Sep 2000
CommentWire
CommentWire

Medrad: the easy path to eCommerce

Published By Datamonitor
22 Sep 2000
CommentWire
CommentWire

Cell Pathways: FDA rejection could spell trouble

Published By Datamonitor
25 Sep 2000
CommentWire
CommentWire

Iberdrola and Endesa: when giants waltz

Published By Datamonitor
26 Sep 2000
CommentWire
CommentWire

Deutsche Telecom: making sacrifices

Published By Datamonitor
26 Sep 2000
CommentWire
CommentWire

Scotia: Foscan falters at the final hurdle

Published By Datamonitor
27 Sep 2000
CommentWire
CommentWire

DuPont / Kos Pharmaceuticals: a good combination for dyslipidemia

Published By Datamonitor
28 Sep 2000

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.